A single-component research material supplied for controlled research environments. Suitable for studies involving GLP-1 receptor–related pathway characterization and method development in model systems.
-
- Weight Loss and Management: GLP-1 drugs, such as Wegovy, Zepbound, and Saxenda, reduce hunger, increase satiety (feeling full), and curb cravings, making them effective for chronic weight management in people with obesity or overweight, often leading to a 5-10% weight loss.
- Improved Blood Sugar Control:
Originally developed for Type 2 diabetes, they enhance insulin secretion only when blood sugar is elevated, reducing the risk of hypoglycemia compared to other treatments.
- Cardiovascular Protection: They provide significant heart benefits, such as reducing the risk of cardiovascular-related death, heart attack, or stroke by up to 20% in patients with established heart disease.
- Reduced Risk of Kidney Disease: Studies have shown they can delay the progression of diabetes-related kidney disease.
- Improved Metabolic Health: They help improve blood pressure and lipid (cholesterol) disorders.
- Reduced Chronic Inflammation: They help reduce inflammation in the body and potentially improve liver health, such as reducing fat in patients with fatty liver disease.
- Potential Neurological Benefits: Emerging research suggests they may provide neuroprotective effects, potentially lowering the risk of Alzheimer's and dementia.
- Reduced Addictive Cravings: Some studies and patient reports suggest a reduction in cravings for alcohol and tobacco, and potential benefits in treating addiction.
PubMed Central (PMC) (.gov) +11
GLP-1 is a natural gut hormone, but pharmaceutical versions act as agonists (mimics) that are more long-lasting. They function by:
- Slowing Gastric Emptying: Food passes slower from the stomach to the intestines, keeping you full longer.
- Acting on the Brain: They reduce appetite signals in the brain.
- Increasing Insulin Secretion: They help the pancreas release the right amount of insulin when blood sugar levels are high.
University of California - Davis Health +2
Composition
• GLP-2 TZ
• Appearance: Lyophilized powder in a sealed research vial
Research Focus (non-clinical)
• Peptide identity and purity assessment via HPLC/LC-MS
• Assay development and calibration for quantitative analysis of GLP-1 receptor–related models
• Chromatographic method optimization for impurity profiling and peak resolution
• Stability characterization of a lyophilized peptide under laboratory storage conditions
For qualified research professionals and institutional laboratories. Not for human use.
Documentation & Quality Assurance
Each lot is sourced through our verified global supply chain with emphasis on traceability and quality control. We work diligently to obtain and maintain third-party analytical reports (HPLC/LC-MS) and Certificates of Analysis for each batch, as part of our ongoing quality process. These documents are reviewed internally and displayed as they become available. Independent third-party testing is also performed on select lots to confirm identity, purity, and alignment with our internal specifications.
Important Notice
This product is intended for laboratory research use only. It is not intended for human or veterinary use, and must not be used for diagnostic, therapeutic, or clinical purposes.
This material is not a drug, medical device, or dietary supplement, and has not been evaluated by the U.S. Food and Drug Administration.
Quality & Manufacturing
All materials are sourced from carefully vetted domestic and international manufacturing partners who follow quality systems consistent with ISO and cGMP principles. Each supplier is reviewed for reliability, documentation integrity, and transparency in testing.
We require a verified purity of 99% or higher and perform independent third-party spot testing to confirm that select lots meet our internal standards for identity, purity, and composition. Where available, endotoxin testing results are included on Certificates of Analysis to verify laboratory purity; their inclusion is for research quality assessment only and does not imply suitability for human or veterinary use.
All research materials are sealed for integrity and packaged for stability during storage and transport from manufacturing through final delivery.
